Metacrine, Inc. Common Stock
MTCR
MTCR was delisted on the 8th of February, 2023.
29 hedge funds and large institutions have $7.29M invested in Metacrine, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 5 closing their positions.
86% more capital invested
Capital invested by funds: $3.93M → $7.29M (+$3.36M)
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
7% more funds holding
Funds holding: 27 → 29 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
63% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.05M |
| 2 |
Millennium Management
New York
|
+$40.1K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$28.7K |
| 4 |
NC
NewSquare Capital
Newtown Square,
Pennsylvania
|
+$248 |
| 5 |
AF
Allworth Financial
Folsom,
California
|
+$207 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CL
CSS LLC
Chicago,
Illinois
|
-$82K |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
-$71K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$66K |
| 4 |
Jane Street
New York
|
-$35.1K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$17K |
MTCR Hedge Fund Activity: Q4 2022 in Review
29 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Metacrine, Inc. Common Stock (MTCR) for Q4 2022, worth a combined $7.29M — up 86% from $3.93M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new MTCR positions and 5 closed out — a net gain of 2 holders — while 3 added to existing stakes and 8 trimmed.
The largest buyer was Tang Capital Management, adding an estimated $1.05M. The largest seller was CSS LLC, exiting entirely with an estimated $82K sold.
- 29 institutional investors held Metacrine, Inc. Common Stock (MTCR) as of Q4 2022, up from 27 in Q3 2022.
- Funds reported $7.29M of Metacrine, Inc. Common Stock stock for Q4 2022, up 86% quarter-over-quarter.
- 7 funds opened new Metacrine, Inc. Common Stock positions in Q4 2022 and 5 closed out, a net change of +2 holders.
- The largest Metacrine, Inc. Common Stock buyer in Q4 2022 was Tang Capital Management, an estimated $1.05M added.
- The largest Metacrine, Inc. Common Stock seller in Q4 2022 was CSS LLC, an estimated $82K sold.
Based on aggregated 13F filings for Q4 2022.